Therapeutic effects of androgens for cachexia

被引:5
作者
Giovanelli, Luca [1 ,2 ,3 ]
Quinton, Richard [3 ,4 ,5 ]
机构
[1] Univ Milan, Dept Med Biotechnol & Translat Med, I-20100 Milan, Italy
[2] IRCCS Ist Auxol Italiano, Dept Endocrine & Metab Med, I-20100 Milan, Italy
[3] Newcastle upon Tyne Hosp, Dept Endocrinol Diabet & Metab, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England
[4] Newcastle Univ, Translat & Clin Res Inst, Newcastle Upon Tyne NE1 3BZ, Tyne & Wear, England
[5] Royal Victoria firmary, Endocrine Unit, Leazes Wing Level 6,Queen Victoria Rd, Newcastle Upon Tyne NE1 4LP, England
关键词
cachexia; muscle wasting; HIV; androgens; testosterone; selective androgen receptor modulators; CHRONIC HEART-FAILURE; CELL LUNG-CANCER; QUALITY-OF-LIFE; LEAN BODY-MASS; PLACEBO-CONTROLLED TRIAL; SKELETAL-MUSCLE PERFORMANCE; HUMAN GROWTH-HORMONE; DOUBLE-BLIND; TESTOSTERONE THERAPY; PHYSICAL FUNCTION;
D O I
10.1016/j.beem.2021.101598
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Cachexia is a complex wasting syndrome, accompanying a variety of end-stage chronic diseases, such as cancer, heart failure and human immunodeficiency virus (HIV) infection/acquired immunodeficiency syndrome (AIDS). It significantly affects patients' quality of life and survival. Multiple therapeutic approaches have been studied over time. However, despite promising results, no drug has been approved to date. In this review, we examine and discuss the available data on the therapeutic effects of androgens and selective androgen receptor modulators (SARMs) for cachexia.(c) 2021 Elsevier Ltd. All rights reserved.
引用
收藏
页数:17
相关论文
共 139 条
  • [21] Muscle contractile and metabolic dysfunction is a common feature of sarcopenia of aging and chronic diseases: From sarcopenic obesity to cachexia
    Biolo, Gianni
    Cederholm, Tommy
    Muscaritoli, Maurizio
    [J]. CLINICAL NUTRITION, 2014, 33 (05) : 737 - 748
  • [22] Characterization of GLPG0492, a selective androgen receptor modulator, in a mouse model of hindlimb immobilization
    Blanque, Roland
    Lepescheux, Lien
    Auberval, Marielle
    Minet, Dominique
    Merciris, Didier
    Cottereaux, Celine
    Clement-Lacroix, Philippe
    Delerive, Philippe
    Namour, Florence
    [J]. BMC MUSCULOSKELETAL DISORDERS, 2014, 15
  • [23] Effects of testosterone replacement on muscle mass and muscle protein synthesis in hypogonadal men - A Clinical research center study
    Brodsky, IG
    Balagopal, P
    Nair, KS
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1996, 81 (10) : 3469 - 3475
  • [24] Synchronous deficits in cumulative muscle protein synthesis and ribosomal biogenesis underlie age-related anabolic resistance to exercise in humans
    Brook, Matthew S.
    Wilkinson, Daniel J.
    Mitchell, William K.
    Lund, Jonathan N.
    Phillips, Bethan E.
    Szewczyk, Nathaniel J.
    Greenhaff, Paul L.
    Smith, Kenneth
    Atherton, Philip J.
    [J]. JOURNAL OF PHYSIOLOGY-LONDON, 2016, 594 (24): : 7399 - 7417
  • [25] Muscle mass and association to quality of life in non-small cell lung cancer patients
    Bye, Asta
    Sjoblom, Bjorg
    Wentzel-Larsen, Tore
    Gronberg, Bjorn H.
    Baracos, Vickie E.
    Hjermstad, Marianne J.
    Aass, Nina
    Bremnes, Roy M.
    Flotten, Oystein
    Jordhoy, Marit
    [J]. JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE, 2017, 8 (05) : 759 - 767
  • [26] Effect of Long-Acting Testosterone Treatment on Functional Exercise Capacity, Skeletal Muscle Performance, Insulin Resistance, and Baroreflex Sensitivity in Elderly Patients With Chronic Heart Failure A Double-Blind, Placebo-Controlled, Randomized Study
    Caminiti, Giuseppe
    Volterrani, Maurizio
    Iellamo, Ferdinando
    Marazzi, Giuseppe
    Massaro, Rosalba
    Miceli, Marco
    Mammi, Caterina
    Piepoli, Massimo
    Fini, Massimo
    Rosano, Giuseppe M. C.
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2009, 54 (10) : 919 - 927
  • [27] Effect of testosterone treatment on the trabecular bone score in older men with low serum testosterone
    Cauley, J. A.
    Ellenberg, S. S.
    Schwartz, A. V.
    Ensrud, K. E.
    Keaveny, T. M.
    Snyder, P. J.
    [J]. OSTEOPOROSIS INTERNATIONAL, 2021, 32 (11) : 2371 - 2375
  • [28] Centers for Disease Control and Prevention, 1987, MMWR S, V36, p1S
  • [29] Prevalence of cachexia in chronic heart failure and characteristics of body composition and metabolic status
    Christensen, Heidi Marie
    Kistorp, Caroline
    Schou, Morten
    Keller, Niels
    Zerahn, Bo
    Frystyk, Jan
    Schwarz, Peter
    Faber, Jens
    [J]. ENDOCRINE, 2013, 43 (03) : 626 - 634
  • [30] Selective androgen receptor modulators: the future of androgen therapy?
    Christiansen, Andrew R.
    Lipshultz, Larry I.
    Hotaling, James M.
    Pastuszak, Alexander W.
    [J]. TRANSLATIONAL ANDROLOGY AND UROLOGY, 2020, 9 : S135 - S148